What is SAS-B (SAS Category B)?
SAS-B means Special Access Scheme Category B — a Therapeutic Goods Administration pathway. In some cases an Australian-registered doctor may apply so a pharmacy can supply a medicine that isn't on the Australian Register of Therapeutic Goods for that use. It isn't a patient DIY scheme, and approval is case by case and can be declined. Peptide Doctor Australia is a matching service; we don't prescribe or apply to the TGA.
11 short questions · about 4 minutes · private and confidential
Want to know whether a telehealth consult is an option for you?
Talk to a real person: free 10-min eligibility callFor Australian residents aged 18+. No obligation. The call is with our patient care team about eligibility and how the service works. It isn't a medical consultation, diagnosis or prescription, and no medical advice is given. The $99 consult fee applies only if you choose to go ahead with a doctor consult.
TGA SAS Category B Explained (Australia) — High-Level Guide
Video transcript
Read the full transcript
What SAS Category B is
What is TGA SAS Category B? In plain English: it's a pathway under Australia's Special Access Scheme.
Doctor applies — not DIY
For some medicines that aren't registered for that use in Australia, an Australian-registered doctor may apply to the TGA so a pharmacy can supply them. Patients don't lodge SAS-B themselves.
Not a guarantee
Approval isn't automatic. The doctor decides whether any pathway is clinically appropriate. A consult does not guarantee a prescription or TGA approval.
How matching fits (and limits)
Peptide Doctor Australia matches adults to partner clinics for telehealth. We don't prescribe or apply to the TGA. A partner clinic calls within forty-eight hours. The $99 consult fee is paid to the partner clinic — nothing on this website. Read more on our SAS-B guide. General information only. Not for emergencies: call 000.
AHPRA-registered Australian doctorsTelehealth Australia-wideConsult fee $99, paid to the partner clinicYour details kept private and confidential
What SAS-B is
SAS-B is Category B of the TGA Special Access Scheme. A registered doctor can apply for approval to supply an unapproved therapeutic good to a named patient when the doctor considers it clinically justified. Unapproved means the good is not on the Australian Register of Therapeutic Goods for that use. It does not mean the TGA has assessed the good as safe or effective for that use. The decision is case by case. Source: TGA – Special Access Scheme.
Who applies to the TGA, me or the doctor?
Your doctor applies, not you. Under SAS Category B, the treating practitioner applies to the TGA for one named patient, and the TGA must approve before supply. Under the Authorised Prescriber scheme, the doctor is authorised in advance. Patients can't apply. The treating doctor applies, not the patient. A pharmacy or a supplier cannot lodge the application instead of the doctor. Peptide Doctor Australia does not lodge SAS Category B applications. Who can prescribe explains the doctor's role.
Is it on the ARTG?
Full answer on are peptides legal in Australia.
What SAS-B is not
It is not automatic approval, not a shop product, and not a way to buy a medicine online lawfully. Approval can be declined. It does not allow supply without a prescriber taking clinical responsibility for that patient. A research-only listing is not permission for human use. The wider access rules are in how to get peptides legally in Australia.
How it relates to a consult
A consult is an assessment. The doctor decides whether any pathway, including SAS Category B, is clinically appropriate. A consult does not guarantee a prescription or TGA approval. The doctor may also decide that no unapproved good is appropriate.
Authorised Prescriber vs SAS-B
Authorised Prescriber is a separate doctor-level TGA authorisation for defined unapproved goods and patient classes. SAS Category B is often one application for one named patient. The detail sits with the TGA and the treating doctor. Read Authorised Prescriber explained. Using this matching service does not mean the doctor is an Authorised Prescriber, and it does not mean SAS Category B will be used.
How Peptide Doctor Australia fits
Peptide Doctor Australia matches adults to partner clinics. We do not prescribe, supply medicines, or apply to the TGA. A partner clinic calls within 48 hours. The $99 consult fee (incl. GST) is paid to the partner clinic — nothing is paid on this website. See how it works, find a clinic and consult cost. Telehealth rules are summarised in is telehealth for peptide therapy legal in Australia. This is general information, not medical advice. In an emergency, call 000.
How the Special Access Scheme works for patients
The Special Access Scheme lets a registered practitioner seek access to a therapeutic good that is not on the Australian Register of Therapeutic Goods for a single named patient. Category B needs TGA approval before supply.
- Assessment by a registered doctor. You consult an AHPRA-registered medical practitioner who takes your history and considers options, including no treatment.
- Clinical decision. If the doctor considers an unapproved good clinically justified, they explain the options, the known and unknown risks, and that the TGA has not evaluated it for quality, safety or efficacy.
- Informed consent. You give informed consent before an application is made. You can ask questions and take time to decide.
- The doctor applies to the TGA. The doctor, not the patient, pharmacy or this website, submits the Category B application with the clinical justification.
- TGA decision. The TGA assesses the application. Supply cannot occur unless it is approved, and approval can be declined.
- Prescription and supply, if approved. If the TGA approves the application, the doctor may issue a prescription and an Australian pharmacy may supply within the terms of that approval.
- Review. The doctor reviews whether continuing is still appropriate. A new application may be needed when an approval ends.
Official sources:
Next step
Talk to an AHPRA-registered Australian doctor by telehealth.
Consult fee $99, paid to the partner clinic · 11 short questions · about 4 minutes · Prescribing decisions rest with the treating doctor
Talk to a real person
Leave your number and our patient care team will call you for a free 10-minute chat about eligibility and how the service works. Not medical advice.
By submitting you agree to be contacted by a partner clinic about your enquiry. See our Privacy Policy.
A doctor's assessment is required. Any treatment is at the doctor's discretion. In an emergency, call 000.
FAQs
- Can I lodge a SAS Category B application myself?
- No. The registered doctor lodges it. Patients do not apply, and Peptide Doctor Australia does not apply to the TGA.
- Can the TGA decline a SAS Category B application?
- No. The TGA can decline an application. A consult does not guarantee a prescription or TGA approval.
- Does using this matching service mean I have SAS approval?
- No. Matching is not a TGA decision. A partner clinic calls within 48 hours for an assessment. The doctor decides whether any pathway is appropriate.
- Is SAS Category B the same as Authorised Prescriber?
- No. SAS Category B is often a one-off application for a named patient. Authorised Prescriber explained is a separate doctor-level authorisation. This website does not appoint Authorised Prescribers.
- Does a SAS approval mean the medicine is approved?
- No. Supply to one patient, if approved, does not mean the TGA has evaluated the goods as safe or effective for that use, and it does not add them to the ARTG.
Sources
- Access pathways for unapproved therapeutic goods — Therapeutic Goods Administration (TGA) — Australian Government
- Special Access Scheme (SAS): Guidance for health practitioners accessing unapproved therapeutic goods — Therapeutic Goods Administration (TGA) — Australian Government
- Access to unapproved therapeutic goods for individual patients (Special Access Scheme) — Therapeutic Goods Administration (TGA) — Australian Government
- Access to unapproved therapeutic goods for multiple patients (Authorised Prescriber) — Therapeutic Goods Administration (TGA) — Australian Government
Sources provide regulatory and educational context only and do not endorse any medicine or this site. See all sources
Related articles
Written by the Peptide Doctor Australia editorial team — last updated 9 November 2026.
General information only, not medical advice. Whether any treatment is appropriate is a decision for a registered doctor after an individual assessment.
Request a consultation
Complete a short health questionnaire to request contact with an AHPRA-registered Australian doctor. Only the doctor can assess whether any treatment is appropriate.
Start your assessment